Edgewise Therapeutics Inc (EWTX)
32.87
-0.39
(-1.17%)
USD |
NASDAQ |
Nov 14, 16:00
32.87
0.00 (0.00%)
Pre-Market: 08:26
Edgewise Therapeutics Net Income (TTM): -124.29M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | -124.29M |
| June 30, 2024 | -115.88M |
| March 31, 2024 | -105.85M |
| December 31, 2023 | -100.16M |
| September 30, 2023 | -89.44M |
| June 30, 2023 | -81.22M |
| March 31, 2023 | -75.82M |
| December 31, 2022 | -67.64M |
| Date | Value |
|---|---|
| September 30, 2022 | -60.92M |
| June 30, 2022 | -56.37M |
| March 31, 2022 | -50.66M |
| December 31, 2021 | -42.81M |
| September 30, 2021 | -36.46M |
| June 30, 2021 | -27.15M |
| March 31, 2021 | -20.75M |
| December 31, 2020 | -17.12M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-124.29M
Minimum
Sep 2024
-17.12M
Maximum
Dec 2020
-67.03M
Average
-64.28M
Median
Net Income (TTM) Benchmarks
| Catalyst Pharmaceuticals Inc | 142.80M |
| Cytokinetics Inc | -576.40M |
| Vanda Pharmaceuticals Inc | -16.39M |
| Vertex Pharmaceuticals Inc | -479.80M |
| Sarepta Therapeutics Inc | 121.84M |